{
    "xml": "<topic id=\"PHP78993\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/caverject-dual-chamber\" basename=\"caverject-dual-chamber\" title=\"Caverject Dual Chamber\">\n<title>Caverject<tm tmtype=\"reg\"/> Dual Chamber</title>\n<topic id=\"PHP79327\" outputclass=\"indicationsAndDose\" rev=\"1.33\" parent=\"/clinical-medicinal-product-information/caverject-dual-chamber\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Erectile dysfunction</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intracavernosal injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 2.5&#8239;micrograms for 1 dose (first dose), followed by 5&#8239;micrograms for 1 dose (second dose), to be given if some response to first dose, alternatively 7.5&#8239;micrograms for 1 dose (second dose), to be given if no response to first dose, then increased in steps of 5&#8211;10&#8239;micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5&#8211;20&#8239;micrograms (max. per dose 60&#8239;micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Erectile dysfunction associated with neurological dysfunction</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intracavernosal injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 1.25&#8239;micrograms for 1 dose (first dose), then 2.5&#8239;micrograms for 1 dose (second dose), then 5&#8239;micrograms for 1 dose (third dose), increased in steps of 5&#8211;10&#8239;micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5&#8211;20&#8239;micrograms (max. per dose 60&#8239;micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Aid to diagnosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intracavernosal injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8211;20&#8239;micrograms for 1 dose (consult product literature).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Aid to diagnosis where evidence of neurological dysfunction</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intracavernosal injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 5&#8239;micrograms (max. per dose 10&#8239;micrograms) for 1 dose, (consult product literature).</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP78993",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/caverject-dual-chamber",
    "basename": "caverject-dual-chamber",
    "title": "Caverject Dual Chamber",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Erectile dysfunction",
                        "html": "Erectile dysfunction"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intracavernosal injection"
                    ],
                    "textContent": "By intracavernosal injection",
                    "html": "By intracavernosal injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 2.5 micrograms for 1 dose (first dose), followed by 5 micrograms for 1 dose (second dose), to be given if some response to first dose, alternatively 7.5 micrograms for 1 dose (second dose), to be given if no response to first dose, then increased in steps of 5&#8211;10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5&#8211;20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.",
                        "html": "<p>Initially 2.5&#8239;micrograms for 1 dose (first dose), followed by 5&#8239;micrograms for 1 dose (second dose), to be given if some response to first dose, alternatively 7.5&#8239;micrograms for 1 dose (second dose), to be given if no response to first dose, then increased in steps of 5&#8211;10&#8239;micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5&#8211;20&#8239;micrograms (max. per dose 60&#8239;micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Erectile dysfunction associated with neurological dysfunction",
                        "html": "Erectile dysfunction associated with neurological dysfunction"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intracavernosal injection"
                    ],
                    "textContent": "By intracavernosal injection",
                    "html": "By intracavernosal injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 1.25 micrograms for 1 dose (first dose), then 2.5 micrograms for 1 dose (second dose), then 5 micrograms for 1 dose (third dose), increased in steps of 5&#8211;10 micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5&#8211;20 micrograms (max. per dose 60 micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.",
                        "html": "<p>Initially 1.25&#8239;micrograms for 1 dose (first dose), then 2.5&#8239;micrograms for 1 dose (second dose), then 5&#8239;micrograms for 1 dose (third dose), increased in steps of 5&#8211;10&#8239;micrograms, to obtain a dose suitable for producing erection lasting not more than 1 hour; if no response to dose then next higher dose can be given within 1 hour, if there is a response the next dose should not be given for at least 24 hours; usual dose 5&#8211;20&#8239;micrograms (max. per dose 60&#8239;micrograms), maximum frequency of injection not more than 3 times per week with at least 24 hour interval between injections.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Aid to diagnosis",
                        "html": "Aid to diagnosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intracavernosal injection"
                    ],
                    "textContent": "By intracavernosal injection",
                    "html": "By intracavernosal injection"
                },
                "adult": [
                    {
                        "textContent": "10&#8211;20 micrograms for 1 dose (consult product literature).",
                        "html": "<p>10&#8211;20&#8239;micrograms for 1 dose (consult product literature).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Aid to diagnosis where evidence of neurological dysfunction",
                        "html": "Aid to diagnosis where evidence of neurological dysfunction"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intracavernosal injection"
                    ],
                    "textContent": "By intracavernosal injection",
                    "html": "By intracavernosal injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 5 micrograms (max. per dose 10 micrograms) for 1 dose, (consult product literature).",
                        "html": "<p>Initially 5&#8239;micrograms (max. per dose 10&#8239;micrograms) for 1 dose, (consult product literature).</p>"
                    }
                ]
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}